PDD Holdings to Report Fourth Quarter and Fiscal Year 2024 Unaudited Financial Results on March 20, 2025
DUBLIN and SHANGHAI, March 13, 2025 ( GLOBE NEWSWIRE ) -- PDD Holdings Inc. ( "PDD Holdings" or the "Company" ) ( NASDAQ: PDD ) today announced that it will report its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2024, before U.S. markets open on ...
Dragonfly Energy to Report Fourth Quarter and Full Year 2024 Financial and Operational Results on March 24, 2025
RENO, Nev., March 13, 2025 ( GLOBE NEWSWIRE ) -- Dragonfly Energy Holdings Corp. ( "Dragonfly Energy" or the "Company" ) ( Nasdaq: DFLI ) , an industry leader in energy storage and battery technology, today announced that the Company will release its financial and operational results for the ...
Indaptus Therapeutics Reports Fourth Quarter and Year-End 2024 Financial Results and Provides Corporate Update
NEW YORK, March 13, 2025 ( GLOBE NEWSWIRE ) -- Indaptus Therapeutics, Inc. ( Nasdaq: INDP ) ( "Indaptus" or the "Company" ) today announces financial results for the fourth quarter and fiscal year ended December 31, 2024 and provides a corporate update.
Heavy-Duty Truck Market to Soar at 9.8% CAGR, Reaching US$ 950.71 Billion by 2034 | Fact.MR Report
Rockville, MD, March 13, 2025 ( GLOBE NEWSWIRE ) -- According to a new industry report compiled by Fact.MR, a market research and competitive intelligence provider, turnover of the global heavy duty truck manufacturing market is analyzed to touch US$ 373.16 billion in 2024 and increase at a CAGR ...
GD Culture Group Limited Announces Closing of Private Placement
NEW YORK, March 13, 2025 ( GLOBE NEWSWIRE ) -- GD Culture Group Limited ( "GDC" or the "Company" ) ( Nasdaq: GDC ) , and its subsidiary, AI Catalysis Corp. ( "AI Catalysis" ) , today announced that the closing of its previously announced private placement ( the "Offering" ) on March 6, 2025 with ...
Tourmaline Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights
- Phase 2 TRANQUILITY trial in patients with elevated high-sensitivity C-reactive protein and chronic kidney disease over-enrolled to 143 total participants, on track to report topline data in the second quarter of 2025 - - Cardiovascular Scientific Advisory Board strengthened with recent ...
FTI Consulting Adds Regulatory Risk and Compliance Expert Michael Herde to Financial Services Offering
WASHINGTON, March 13, 2025 ( GLOBE NEWSWIRE ) -- FTI Consulting, Inc. ( NYSE: FCN ) today announced the appointment of Michael Herde as a Senior Managing Director in the firm's Forensic and Litigation Consulting segment.
